Marc Scheineson is quoted on the FDA’s consideration of an experimental treatment for Lou Gehrig’s disease.
In the News
September 25, 2023
Associated Press | Experimental Treatment Pushed by ALS Patients Gets Day Before FDA, but Agency Unconvinced It Works
Media Contact